Skip to main content
Pfizer COVID-19 vaccine appointments are available to our patients.
Sign up for Connect today
to schedule your vaccination.
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Jill Roberts Center for Inflammatory Bowel Disease
Explore this Website
Home
About Us
Toggle About Us menu options
Clinical Staff
Research Staff
Contact Us
Newsworthy
Toggle Newsworthy menu options
News and Announcements
Patient Care
Toggle Patient Care menu options
Clinical Services
FAQs
For Your Visit
COVID-19 Information
Nutrition Science
Toggle Nutrition Science menu options
Nutrition FAQs
Food Intolerances
News in IBD Nutrition
Research and Clinical Trials
Toggle Research and Clinical Trials menu options
Clinical Trials
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Newsworthy
Patient Care
Nutrition Science
Research and Clinical Trials
Home
Publications
Publications
Clinical Trials
Publications
Publications
Found 33 results
Author
Title
[
Type
]
Year
Filters:
First Letter Of Last Name
is
F
[Clear All Filters]
Journal Article
Narula N
,
Peerani F
,
Meserve J
,
Kochhar G
,
Chaudrey K
,
Hartke J
,
Chilukuri P
,
Koliani-Pace J
,
Winters A
,
Katta L
et al.
. 2018.
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
.
Am J Gastroenterol. 113(9):1345.
Narula N
,
Peerani F
,
Meserve J
,
Kochhar G
,
Chaudrey K
,
Hartke J
,
Chilukuri P
,
Koliani-Pace J
,
Winters A
,
Katta L
et al.
. 2018.
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
.
Am J Gastroenterol. 113(9):1345.
Sedano R
,
Hogan M
,
Nguyen TM
,
Chang J
,
Zou GY
,
Macdonald JK
,
Casteele NVande
,
Hanzel J
,
Crowley E
,
Battat R
et al.
. 2021.
Systematic review and Meta-analysis: Clinical, Endoscopic, Histologic and Safety Placebo Rates in Induction and Maintenance trials of Ulcerative Colitis.
.
J Crohns Colitis.
Faleck DM
,
Winters A
,
Chablaney S
,
Shashi P
,
Meserve J
,
Weiss A
,
Aniwan S
,
Koliani-Pace JL
,
Kochhar G
,
Boland BS
et al.
. 2019.
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.
.
Clin Gastroenterol Hepatol. 17(12):2497-2505.e1.
Faleck DM
,
Winters A
,
Chablaney S
,
Shashi P
,
Meserve J
,
Weiss A
,
Aniwan S
,
Koliani-Pace JL
,
Kochhar G
,
Boland BS
et al.
. 2019.
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.
.
Clin Gastroenterol Hepatol. 17(12):2497-2505.e1.
Dogan B
,
Fu J
,
Zhang S
,
Scherl EJ
,
Simpson KW
. 2018.
Rifaximin decreases virulence of Crohn's disease-associated Escherichia coli and epithelial inflammatory responses.
.
J Antibiot (Tokyo). 71(5):485-494.
Sandborn WJ
,
Feagan BG
,
Fedorak RN
,
Scherl E
,
Fleisher MR
,
Katz S
,
Johanns J
,
Blank M
,
Rutgeerts P
. 2008.
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.
.
Gastroenterology. 135(4):1130-41.
Sandborn WJ
,
Feagan BG
,
Fedorak RN
,
Scherl E
,
Fleisher MR
,
Katz S
,
Johanns J
,
Blank M
,
Rutgeerts P
. 2008.
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.
.
Gastroenterology. 135(4):1130-41.
Sandborn WJ
,
Feagan BG
,
Fedorak RN
,
Scherl E
,
Fleisher MR
,
Katz S
,
Johanns J
,
Blank M
,
Rutgeerts P
. 2008.
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.
.
Gastroenterology. 135(4):1130-41.
Lewis JD
,
Sandler RS
,
Brotherton C
,
Brensinger C
,
Li H
,
Kappelman MD
,
Daniel SG
,
Bittinger K
,
Albenberg L
,
Valentine JF
et al.
. 2021.
A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn's Disease.
.
Gastroenterology. 161(3):837-852.e9.
Lewis JD
,
Sandler RS
,
Brotherton C
,
Brensinger C
,
Li H
,
Kappelman MD
,
Daniel SG
,
Bittinger K
,
Albenberg L
,
Valentine JF
et al.
. 2021.
A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn's Disease.
.
Gastroenterology. 161(3):837-852.e9.
Shmidt E
,
Kochhar G
,
Hartke J
,
Chilukuri P
,
Meserve J
,
Chaudrey K
,
Koliani-Pace JL
,
Hirten R
,
Faleck D
,
Barocas M
et al.
. 2018.
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.
.
Inflamm Bowel Dis. 24(11):2461-2467.
Shmidt E
,
Kochhar G
,
Hartke J
,
Chilukuri P
,
Meserve J
,
Chaudrey K
,
Koliani-Pace JL
,
Hirten R
,
Faleck D
,
Barocas M
et al.
. 2018.
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.
.
Inflamm Bowel Dis. 24(11):2461-2467.
Decalf J
,
Fernandes S
,
Longman R
,
Ahloulay M
,
Audat F
,
Lefrerre F
,
Rice CM
,
Pol S
,
Albert ML
. 2007.
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients.
.
J Exp Med. 204(10):2423-37.
Lukin DJ
,
Funez-dePagnier G
,
Lima S
,
Lai D
,
Duenas-Bianchi L
,
Ahmed W
,
Jacob V
,
Battat R
,
Scherl E
,
Longman RS
. 2021.
No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD.
.
Clin Gastroenterol Hepatol. 19(11):2312-2314.e3.
Ma C
,
Sedano R
,
Almradi A
,
Casteele NVande
,
Parker CE
,
Guizzetti L
,
Schaeffer DF
,
Riddell RH
,
Pai RK
,
Battat R
et al.
. 2021.
An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials.
.
Gastroenterology. 160(7):2291-2302.
Ma C
,
Battat R
,
Dulai PS
,
Parker CE
,
Sandborn WJ
,
Feagan BG
,
Jairath V
. 2019.
Innovations in Oral Therapies for Inflammatory Bowel Disease.
.
Drugs. 79(12):1321-1335.
Dulai PS
,
Battat R
,
Barsky M
,
Nguyen NH
,
Ma C
,
Narula N
,
Mosli M
,
Casteele NVande
,
Boland BS
,
Prokop L
et al.
. 2020.
Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors.
.
Am J Gastroenterol. 115(6):885-894.
Kayal M
,
Ungaro RC
,
Riggs A
,
Kamal K
,
Agrawal M
,
Cohen-Mekelburg S
,
Axelrad J
,
Faye A
,
Scherl E
,
Lawlor G
et al.
. 2021.
Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability.
.
Clin Gastroenterol Hepatol.
Battat R
,
Duijvestein M
,
Guizzetti L
,
Choudhary D
,
Boland BS
,
Dulai PS
,
Parker CE
,
Nguyen TM
,
Singh S
,
Casteele NVande
et al.
. 2019.
Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
.
Am J Gastroenterol. 114(5):733-745.
Cohen-Mekelburg S
,
Rosenblatt R
,
Gold S
,
Shen N
,
Fortune B
,
Waljee AK
,
Saini S
,
Scherl E
,
Burakoff R
,
Unruh M
. 2019.
Fragmented Care is Prevalent Among Inflammatory Bowel Disease Readmissions and is Associated With Worse Outcomes.
.
Am J Gastroenterol. 114(2):276-290.
Lukin DJ
,
Lawlor G
,
Hudesman DP
,
Durbin L
,
Axelrad JE
,
Passi M
,
Cavaliere K
,
Coburn E
,
Loftus M
,
Jen H
et al.
. 2019.
Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
.
Inflamm Bowel Dis. 25(4):775-781.
Sandborn WJ
,
Feagan BG
,
Loftus EV
,
Peyrin-Biroulet L
,
Van Assche G
,
D'Haens G
,
Schreiber S
,
Colombel J-F
,
Lewis JD
,
Ghosh S
et al.
. 2020.
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease.
.
Gastroenterology. 158(8):2123-2138.e8.
Agrawal M
,
Cohen-Mekelburg S
,
Kayal M
,
Axelrad J
,
Galati J
,
Tricomi B
,
Kamal K
,
Faye AS
,
Abrudescu P
,
Scherl E
et al.
. 2019.
Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio-economic factors.
.
Aliment Pharmacol Ther. 49(5):564-571.
Shen B
,
Kochhar GS
,
Kariv R
,
Liu X
,
Navaneethan U
,
Rubin DT
,
Cross RK
,
Sugita A
,
D'Hoore A
,
Schairer J
et al.
. 2021.
Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium.
.
Lancet Gastroenterol Hepatol. 6(10):826-849.
1
(current)
2
next ›
last »